![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Genet. , 26 June 2024
Sec. Cancer Genetics and Oncogenomics
Volume 15 - 2024 | https://doi.org/10.3389/fgene.2024.1440802
This article is part of the Research Topic Screening and discovering novel biological biomarkers by omic-data to revolutionize tumor management View all 7 articles
This article is a correction to:
Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma
A Corrigendum on
Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma
by Chen D, Zhang C, Zang Y, Wang W and Zhang J (2022). Front. Genet. 13:970900. doi: 10.3389/fgene.2022.970900
In the published article, there was an error in the Affiliations. The corrected affiliations and corresponding author attributions appear below.
“Dongshan Chen1,‡, Chen Zhang2,‡, Yuanwei Zang3,‡, Wei Wang1,*,† and Jiandong Zhang1,4,5,*,†,‡”.
“1Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, Beijing, China
2School of Life Science and Engineering, Handan University, Handan, China
3Department of Urology, Qilu Hospital of Shandong University, Jinan, China
4Department of Urology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China
5Department of Urology, Tongji Hospital, Tongji Medical College, Wuhan, China”.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: immune cell infiltration, immune-related genes, papillary renal cell carcinoma, prognostic index, immunotherapy
Citation: Chen D, Zhang C, Zang Y, Wang W and Zhang J (2024) Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma. Front. Genet. 15:1440802. doi: 10.3389/fgene.2024.1440802
Received: 30 May 2024; Accepted: 12 June 2024;
Published: 26 June 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Chen, Zhang, Zang, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiandong Zhang, eWpzMjAxMHpqZEAxMjYuY29t; Wei Wang, d2Vpd2FuZzA5MjBAMTYzLmNvbQ==
†ORCID: Wei Wang, orcid.org/0000-0003-2642-3338; Jiandong Zhang, orcid.org/0000-0002-3042-2381
‡These authors have contributed equally to this work and share first authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.